ME
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
10.995
Exchange
XNAS - Nasdaq
60 %
Last period ROIC
47%
ROIC has increased in 5 years
What is ROIC ?
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Medpace
Company Analysis
MEDP valuation, rating, competitors, insights and company profile
Eyestock Rating
MEDP financial analysis by Eyestock methodology
Valuation
MEDP valuation using historical relative method
Statements
MEDP Income Statements, Balance Sheet and Cash Flow Statements
Dividends
MEDP dividend yield and annual dividend
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
Medpace`s ROIC for the last twelve months ended 2024-06-30 is 60 %
